1. Home
  2. PRAX vs SEB Comparison

PRAX vs SEB Comparison

Compare PRAX & SEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • SEB
  • Stock Information
  • Founded
  • PRAX 2015
  • SEB 1918
  • Country
  • PRAX United States
  • SEB United States
  • Employees
  • PRAX N/A
  • SEB N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • SEB Farming/Seeds/Milling
  • Sector
  • PRAX Health Care
  • SEB Industrials
  • Exchange
  • PRAX Nasdaq
  • SEB Nasdaq
  • Market Cap
  • PRAX 4.0B
  • SEB 3.3B
  • IPO Year
  • PRAX 2020
  • SEB N/A
  • Fundamental
  • Price
  • PRAX $179.18
  • SEB $3,963.50
  • Analyst Decision
  • PRAX Strong Buy
  • SEB
  • Analyst Count
  • PRAX 12
  • SEB 0
  • Target Price
  • PRAX $212.42
  • SEB N/A
  • AVG Volume (30 Days)
  • PRAX 978.5K
  • SEB 4.6K
  • Earning Date
  • PRAX 11-05-2025
  • SEB 10-28-2025
  • Dividend Yield
  • PRAX N/A
  • SEB 0.22%
  • EPS Growth
  • PRAX N/A
  • SEB N/A
  • EPS
  • PRAX N/A
  • SEB 410.34
  • Revenue
  • PRAX $7,463,000.00
  • SEB $9,818,000,000.00
  • Revenue This Year
  • PRAX N/A
  • SEB N/A
  • Revenue Next Year
  • PRAX $44.43
  • SEB N/A
  • P/E Ratio
  • PRAX N/A
  • SEB $9.50
  • Revenue Growth
  • PRAX 364.98
  • SEB 10.31
  • 52 Week Low
  • PRAX $26.70
  • SEB $2,365.00
  • 52 Week High
  • PRAX $206.71
  • SEB $4,038.54
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 62.04
  • SEB 72.24
  • Support Level
  • PRAX $159.74
  • SEB $3,140.01
  • Resistance Level
  • PRAX $188.53
  • SEB $3,826.73
  • Average True Range (ATR)
  • PRAX 13.41
  • SEB 152.82
  • MACD
  • PRAX -5.00
  • SEB 69.50
  • Stochastic Oscillator
  • PRAX 47.30
  • SEB 100.00

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

About SEB Seaboard Corporation

Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.

Share on Social Networks: